[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL156775A0 - Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases - Google Patents

Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases

Info

Publication number
IL156775A0
IL156775A0 IL15677502A IL15677502A IL156775A0 IL 156775 A0 IL156775 A0 IL 156775A0 IL 15677502 A IL15677502 A IL 15677502A IL 15677502 A IL15677502 A IL 15677502A IL 156775 A0 IL156775 A0 IL 156775A0
Authority
IL
Israel
Prior art keywords
carbonylaminoketones
cruzipain
inhibitors
cyclic
cysteine proteases
Prior art date
Application number
IL15677502A
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0101187.3A external-priority patent/GB0101187D0/en
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Publication of IL156775A0 publication Critical patent/IL156775A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15677502A 2001-01-17 2002-01-17 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases IL156775A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0101187.3A GB0101187D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27550501P 2001-03-13 2001-03-13
PCT/GB2002/000190 WO2002057249A1 (en) 2001-01-17 2002-01-17 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases

Publications (1)

Publication Number Publication Date
IL156775A0 true IL156775A0 (en) 2004-02-08

Family

ID=26245572

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15677502A IL156775A0 (en) 2001-01-17 2002-01-17 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases

Country Status (6)

Country Link
EP (1) EP1362042A1 (en)
JP (1) JP2004522738A (en)
CA (1) CA2435117A1 (en)
IL (1) IL156775A0 (en)
NZ (1) NZ526914A (en)
WO (1) WO2002057249A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383748A2 (en) 2000-12-22 2004-01-28 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
MXPA04002282A (en) 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Novel compounds and compositions as cathepsin inhibitors.
YU34604A (en) 2001-11-14 2006-08-17 Aventis Pharmaceuticals Inc. Oligopeptides and compositions containing them as cathepsin s inhibitors
WO2006064286A1 (en) * 2004-12-13 2006-06-22 Medivir Uk Ltd Cathepsin s inhibitors
WO2012099785A2 (en) 2011-01-20 2012-07-26 The Regents Of The University Of Colorado, A Body Corporate Modulators of tlr3/dsrna complex and uses thereof
WO2014034750A1 (en) * 2012-08-30 2014-03-06 国立大学法人 東京大学 Endoparasite control agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923535A4 (en) * 1996-08-28 2001-01-10 Smithkline Beecham Corp Inhibitors of cysteine protease
TR199901343T2 (en) * 1996-12-23 1999-09-21 Elan Pharmaceuticals, Inc. To inhibit the release and/or synthesis of β-amyloid peptide using cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions containing them, and such compounds. in methods.
AR013079A1 (en) * 1997-05-06 2000-12-13 Smithkline Beecham Corp SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS
CO5150165A1 (en) * 1998-11-13 2002-04-29 Smithkline Beecham Plc PROTEASE INHIBITORS: KATEPSIN K TYPE
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s

Also Published As

Publication number Publication date
NZ526914A (en) 2005-02-25
CA2435117A1 (en) 2002-07-25
WO2002057249A1 (en) 2002-07-25
JP2004522738A (en) 2004-07-29
EP1362042A1 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
HUP0304052A3 (en) Heterocyclic inhibitors of erk2 and uses thereof
IL161992A0 (en) Substituted 2-amino-cycloalkanecarboxamides and t heir use as cysteine protease inhibitors
HK1060565A1 (en) Spiroheterocyclic nitroles useful as reversible inhibitors of cysteine proteases
HK1064284A1 (en) Antibody inhibitors of gdf-8 and uses thereof gdf-8
EP1448218A4 (en) Beta-secretase inhibitors and methods of use
EP1538907A4 (en) Inhibitors of ftsz and uses thereof
AU2003303128A8 (en) Inhibitors and methods of use thereof
AU2002328946A1 (en) Irreversible cysteine protease inhibitors of legumain
NO20041180L (en) Pyrrolopyrimidines as agents for inhibition of cysteine proteases
AU2002340031A1 (en) Compounds useful as reversible inhibitors of cysteine proteases
ATE281181T1 (en) COMBINATION OF GABA AGONISTS AND SORBITOL DEHYDROGENASE INHIBITORS
EP1549316A4 (en) INHIBITORS OF TFGbeta
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1420651A4 (en) Preservation of produce
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
IL156775A0 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
IL156776A0 (en) Inhibitors of cruzipain and other cysteine proteases
IL160794A0 (en) An enantiomerically pure diarylmethylpiperazine and methods of using same
AU2003233279A8 (en) Non-covalent inhibitors of cysteine proteases with atripeptide backbone
ZA200305259B (en) Inhibitors of cruzipain and other cysteine proteases.
ZA200305260B (en) Inhibitors of cruzipain and other cysteine proteases.
AU2002219398A1 (en) Inhibitors of cruzipain and other cysteine proteases
IL160230A0 (en) Use of il-18 inhibitors
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
EP1414427A4 (en) Kavalactone compositions and methods of use